Natco Pharma Limited Seeks 'Compulsory License' For Copy Of Pfizer Inc. Drug

Published: Jan 05, 2011

Dow Jones -- Natco Pharma Ltd. (524816.BY) said Wednesday it has informed Pfizer Inc. (PFE) that it wants to make and sell a low-cost generic version of the U.S. company's maraviroc for treating the HIV infection under a so-called "compulsory license."

Back to news